Type of sarcoma: Sarcomas with specific genetic markers or mutations
Full title: A Phase 2 Study of Erdafitinib in subjects with advanced solid tumours and fibroblast growth factor receptor gene alterations
Locations: Bristol Royal Hospital for Children, Bristol Haematology and Oncology Centre, Great Ormond Street Hospital, The Christie, Freeman Hospital, Derriford Hospital, The Royal Marsden, The Clatterbridge
This study aims to find out how effective erdafitinib is in terms of overall response rate (ORR) in patients with advanced solid tumors with fibroblast growth factor receptor (FGFR) mutations and gene fusions.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.